Burton PS - Search Results

1

Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers.

Adson A, Raub TJ, Burton PS, Barsuhn CL, Hilgers AR, Audus KL, Ho NF. Adson A, et al. Among authors: burton ps. J Pharm Sci. 1994 Nov;83(11):1529-36. doi: 10.1002/jps.2600831103. J Pharm Sci. 1994. PMID: 7891269

2

A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.

Hugger ED, Novak BL, Burton PS, Audus KL, Borchardt RT. Hugger ED, et al. Among authors: burton ps. J Pharm Sci. 2002 Sep;91(9):1991-2002. doi: 10.1002/jps.10176. J Pharm Sci. 2002. PMID: 12210046

3

Automated analysis of polyethylene glycol-induced inhibition of P-glycoprotein activity in vitro.

Hugger ED, Cole CJ, Raub TJ, Burton PS, Borchardt RT. Hugger ED, et al. Among authors: burton ps. J Pharm Sci. 2003 Jan;92(1):21-6. doi: 10.1002/jps.10265. J Pharm Sci. 2003. PMID: 12486678

4

Quantitative and Mechanistic Assessment of Model Lipophilic Drugs in Micellar Solutions in the Transport Kinetics Across MDR1-MDCK Cell Monolayers.

Ho NFH, Nielsen J, Peterson M, Burton PS. Ho NFH, et al. Among authors: burton ps. J Pharm Sci. 2016 Feb;105(2):904-914. doi: 10.1016/j.xphs.2015.11.028. J Pharm Sci. 2016. PMID: 26869435

5

Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.

Nerurkar MM, Ho NF, Burton PS, Vidmar TJ, Borchardt RT. Nerurkar MM, et al. Among authors: burton ps. J Pharm Sci. 1997 Jul;86(7):813-21. doi: 10.1021/js960483y. J Pharm Sci. 1997. PMID: 9232522

6

Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers.

Adson A, Burton PS, Raub TJ, Barsuhn CL, Audus KL, Ho NF. Adson A, et al. Among authors: burton ps. J Pharm Sci. 1995 Oct;84(10):1197-204. doi: 10.1002/jps.2600841011. J Pharm Sci. 1995. PMID: 8801334

7

The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.

Nerurkar MM, Burton PS, Borchardt RT. Nerurkar MM, et al. Among authors: burton ps. Pharm Res. 1996 Apr;13(4):528-34. doi: 10.1023/a:1016033702220. Pharm Res. 1996. PMID: 8710741

8

Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides.

Chikhale EG, Ng KY, Burton PS, Borchardt RT. Chikhale EG, et al. Among authors: burton ps. Pharm Res. 1994 Mar;11(3):412-9. doi: 10.1023/a:1018969222130. Pharm Res. 1994. PMID: 8008709

9

A biophysical model of passive and polarized active transport processes in Caco-2 cells: approaches to uncoupling apical and basolateral membrane events in the intact cell.

Ho NF, Burton PS, Conradi RA, Barsuhn CL. Ho NF, et al. Among authors: burton ps. J Pharm Sci. 1995 Jan;84(1):21-7. doi: 10.1002/jps.2600840107. J Pharm Sci. 1995. PMID: 7714738

10

How structural features influence the biomembrane permeability of peptides.

Burton PS, Conradi RA, Ho NF, Hilgers AR, Borchardt RT. Burton PS, et al. J Pharm Sci. 1996 Dec;85(12):1336-40. doi: 10.1021/js960067d. J Pharm Sci. 1996. PMID: 8961149 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results